Are you Dr. Coyle?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 64 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
375 Dixmyth Ave
Cincinnati, OH 45220Phone+1 513-853-1300Fax+1 513-451-1356- Is this information wrong?
Summary
- Dr. Thomas Coyle, MD is an oncologist in Cincinnati, Ohio. He is currently licensed to practice medicine in Ohio, Florida, and New York. He is affiliated with Good Samaritan Hospital, Select Specialty Hospital-Cincinnati, and Bethesda North Hospital.
Education & Training
SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 1988 - 1989
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1985 - 1987- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1982 - 1985
SUNY Upstate Medical UniversityClass of 1982
Certifications & Licensure
NY State Medical License 1983 - Present
OH State Medical License 2015 - 2023
FL State Medical License 1996 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2007
Clinical Trials
- Rivaroxaban Effects in Subjects Who Have Undergone Gastric Bypass Surgery Start of enrollment: 2014 Dec 01
Publications & Presentations
PubMed
- 2 citationsComplete response to temozolomide in chronic lymphocytic leukemia.Archana Rao, Nisha S. Ramani, Robert Stoppacher, Thomas Coyle> ;Clinical Case Reports. 2017 May 31
- 2 citationsCrizotinib in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the setting of renal insufficiency: a case report.Shalin Kothari, Najam Ud-Din, Michele Lisi, Thomas Coyle> ;Journal of Medical Case Reports. 2016 Jun 14
- 14 citationsPPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244.Heinrich Elinzano, Michael Glantz, Maciej M. Mrugala, Santosh Kesari, David Piccioni, Lyndon Kim, Edward Pan, Shakeeb Yunus, Thomas Coyle, Kinsella Timothy, Devon Evan...> ;American Journal of Clinical Oncology. 2015 Dec 9
- Join now to see all
Professional Memberships
- Member
- Fellow
Hospital Affiliations
Bethesda North HospitalCincinnati, Ohio
Good Samaritan HospitalCincinnati, Ohio- Select Specialty Hospital-CincinnatiCincinnati, Ohio
